June 10, 2005
Drug Firms Control Trials, Study Finds
Academic medical centers tolerate widely differing levels of drug-company control of the clinical trials they conduct, according to a study published last month in The New England Journal of Medicine.
In the study, researchers report that no consensus exists on many issues in industry-financed clinical research, such as whether pharmaceutical-company sponsors can draft manuscripts to be published in cooperation with academic researchers.
The study suggests that such diversity in
This is an article for subscribers only. You may access this article by purchasing a:
Digital or Print Subscription
Web Pass
Already have an account? Log In Now.
-
Off Beat
-
The Chronicle Review
-
Administration
